Shubing Zhang
6PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 23, 2025
Calothrixin B by docking JAK2 is a potential therapeutic inhibitor for pancreatic ductal adenocarcinoma.Yang Wang, Sayed S Esa, Rongji Yu
|Feb 11, 2024
Targeting C21orf58 is a Novel Treatment Strategy of Hepatocellular Carcinoma by Disrupting the Formation of JAK2/C21orf58/STAT3 Complex.Hao Jiang, Yang Wang, Doudou Wen
|Jan 19, 2024
COX6C expression driven by copy amplification of 8q22.2 regulates cell proliferation via mediation of mitosis by ROS-AMPK signaling in lung adenocarcinoma.Shuanghui Liu, Fanggui Shao, Yourong Wang
|Dec 22, 2023
STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient.Shubing Zhang, Jinhua Yan, Lan He
|Aug 24, 2023
A novel RBBP8(p.E281*) germline mutation is a predisposing mutation in familial hereditary cancer syndrome.Jinhua Yan, Jinzheng Wu, Yang Wang
|May 06, 2020
Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer.Jun Chang, Ling Hong, Yaozhong Liu
Pageof 1
